News

Article

Particle Sciences Gains DEA Schedule I Registration

Expanded controlled substance capabilities enables Particle Sciences to develop and manufacture Schedule I–V drugs.

Particle Sciences, a Lubrizol LifeSciences company and pharmaceutical contract development and manufacturing organization, announced on May 23, 2019 that it received Drug Enforcement Administration (DEA) registration to be an authorized manufacturer of Schedule I substances.

The expanded registration will allow the company to conduct analytical testing, development, and manufacturing of cannabis-derived materials to be used in pharmaceutical applications for medically justified, legal uses in the United States.

The company reports existing capabilities to develop and manufacture Schedule II–V controlled drug products at its facility in Bethlehem, PA. Previously, the company worked on projects ranging from a novel nasal delivery system for diazepam to long-acting buprenorphine dosage forms. 

“Particle Sciences has built a solid reputation and specialized expertise in controlled substances as a result of our team’s work in complex formulations with substances in Schedules II–V,” said Robert Lee, president of Particle Sciences in a press statement announcing the approval. “A high level of ethical standards and water-tight controls/processes including accurate documentation are essential to carry out controlled substances work and these are already firmly ingrained in our day-to-day operations.”

Source: Particle Sciences

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More